Drugdu.com expert's response:

The Process for Obtaining a Medical Device Product Registration Certificate Involves Multiple Steps, Detailed as Follows:

I. Preliminary Preparation and Classification Confirmation

Product Classification Determination: Based on the Medical Device Classification Catalog and classification criteria, the category is determined by considering factors such as the intended use and mechanism of action of the product. For example, blood glucose test strips fall under Class II, while artificial heart valves are classified as Class III. If no matching category can be found in the existing catalog, a classification determination must be conducted beforehand.

Selection of Registration Pathway: Domestic enterprises should proceed with the registration process, while imported products must appoint a domestic agent. For renewal of registration, applications should be submitted six months prior to the expiration of the certificate.

Preparation of Technical Requirement Documents: These documents should cover product standards, performance indicators, and test reports, referencing relevant standards. For instance, orthopedic implants must include test data on fatigue strength and corrosion resistance.

Establishment of Risk Management Documentation: A risk management system should be established in accordance with the YY/T 0316 standard, including records of risk analysis, evaluation, and control. Typical risks, such as electromagnetic interference, require the formulation of protective measures.

Preparation of Clinical Evaluation Data: Except for products listed in the exemption catalog for clinical trials, Class II/III devices must demonstrate safety through clinical trials or comparison with similar products. Clinical trials should be conducted at registered medical institutions, with a typical sample size of no less than 200 cases for Class III devices.

Establishment of Quality Management System Documentation: Manufacturers must establish a system that complies with the Good Manufacturing Practice for Medical Devices, covering modules such as plant facilities, equipment validation, and material control.

II. Compilation and Submission of Application Materials

Compilation of Application Materials: Submit the registration application form, technical documents, and other materials through the NMPA electronic submission system. Imported products must include proof of marketing in the country of origin and notarized documents. Domestic enterprises should prepare documents such as the domestic medical device registration application form, qualification certificates, and product technical requirements.

Submission Methods:

Online Submission: Electronic materials that comply with the Technical Guide for Electronic Submission of Medical Device Registration Applications (Trial) can be submitted via the web portal or the eRPS client.

Offline Submission: Applications can be scheduled for on-site processing through the online appointment system of the National Medical Products Administration's Administrative Acceptance Service Hall between 7:00 AM and 11:00 PM daily. Alternatively, direct visits to the hall without online appointments are also acceptable.

III. Formal Review and Evaluation

Formal Review: The drug regulatory authority completes the initial review within five working days. Common issues requiring supplementary materials include missing paging seals on test reports and unregistered clinical protocols. If the materials meet the requirements, the center will formally accept the application and issue an "Acceptance Notice" and a "Fee Payment Notice." If not, the materials will be returned, along with a "Notice for Supplementary Materials" or a "Notice of Rejection."

Evaluation Cycle Management: The statutory evaluation time limits are 60 days for Class II and 90 days for Class III devices, with the actual cycle influenced by the number of supplementary material requests.

IV. Supplementary Material Requests and Rectification

Supplementary Material Notices: If issues are identified during the evaluation process, the drug regulatory authority will issue a notice requesting supplementary materials to be completed within a specified timeframe.

Rectification Response: Upon receiving the supplementary material notice, the applicant must complete the supplementation within one year. The rectification content should address the issues raised by the drug regulatory authority to ensure the safety and effectiveness of the product.

V. Approval and Certificate Issuance

Approval Decision: After evaluation and rectification, the drug regulatory authority will make a decision to approve or reject the application.

Certificate Issuance: If the application is successful, a medical device product registration certificate will be issued. The certificate specifies key information such as the product name and model specifications. Any changes to this information require an application for alteration of the permitted items.

VI. Ongoing Supervision and Maintenance

Continuous Monitoring Requirements: Establish a direct reporting system for adverse events, with death events reported within 24 hours and serious injuries within 15 days.

On-Site Inspections: The drug regulatory department may conduct dynamic production inspections, focusing on design and development documentation, sterilization records, and traceability of test data.

Certificate Renewal and Alteration: The registration certificate is typically valid for five years, and enterprises must apply for renewal before its expiration. If there are changes to product information, an application for alteration of the registration certificate must be promptly submitted to the drug regulatory department.